The short session in 2020 focused almost exclusively on COVID-19 related expenditures and concerns with revenue shortfalls. While many issues were set aside with the pandemic, there has also been opportunity for the life science industry to better tell its story as it works to provide therapies and vaccines.
This will be a great opportunity to hear from the Life Science Caucus leaders, who are committed to being strong supporters for the industry.
Senator Paul Newton, Co-chair, Life Science Caucus (R-Cabarrus, Union)
Senator Mike Woodard, Co-chair, Life Science Caucus (D-Durham, Granville, Person)
Representative Donna McDowell White, Co-chair, Life Science Caucus (R-Johnston)
Representative Robert Reives, Co-chair, Life Science Caucus, (D-Chatham, Durham)
Join us for this legislative session summary, moderated by NCBIO President, Sam Taylor.
Thank you to our sponsors: BIO, Novo Nordisk, PhRMA, and UCB.